期刊文献+

艾司西酞普兰与帕罗西汀治疗老年抑郁症对比分析 被引量:19

Comparative study of escitalopram and paroxetine on the elderly patients with depression
下载PDF
导出
摘要 目的探讨艾司西酞普兰与帕罗西汀治疗老年抑郁症患者的临床效果。方法选取2012-01—2012-12我院收治的老年抑郁症患者88例,随机分为艾司西酞普兰组和帕罗西汀组,每组44例。艾司西酞普兰组采用草酸艾司西酞普兰片治疗,帕罗西汀组采用盐酸帕罗西汀片治疗,比较2组患者的临床疗效和并发症发生情况。结果艾司西酞普兰组痊愈率和总有效率分别为52.27%、93.18%,均明显高于帕罗西汀组的36.36%、77.27%,差异均具有统计学意义(P<0.05);艾司西酞普兰组口干、恶心、头痛、出汗、便秘等不良反应发生率较帕罗西汀组均呈不同程度降低,但差异均无统计学意义(P>0.05)。结论艾司西酞普兰治疗老年抑郁症,其疗效确切,效果显著,安全性高,是老年抑郁症患者较为理想的临床治疗药物。 Objective To explore the clinical effect of escitalopram and paroxetine on elderly patients with depres sion. Methods Totally 88 elderly patients with depression in our hospital from January 2012 to December 2012 were selected and were divided into escitalopram group and paroxetine group randomly. There were 44 cases in each group. The escitalopram group was treated with escitalopram oxalate tablets. The paroxetine group was treated with paroxetine hydrochloride. The clinical treatment and complications of the patients in two groups were compared and analyzed. Results The curative rate and total effective rate of escitalopram group (52.57% and 93.18%) were significantly higher than them of paroxetine group (36.36 and 77.27%, P〈0.05). Compared with paroxeline group, the incidences of adverse reactions including dry mouth, nausea, headache, sweating and constipation of the escitalopram group were lower, but there were no significant differences (P 〉0.05). Conclusion Eseitalopram is significantly efficacious and safe in the treatment of elderly patients with depression. It is the ideal clinical treatment drugs for them.
出处 《中国实用神经疾病杂志》 2013年第23期56-57,共2页 Chinese Journal of Practical Nervous Diseases
关键词 艾司西酞普兰 帕罗西汀 老年抑郁症 Escitalopram Paroxetine Elderly patients with depression
  • 相关文献

参考文献5

二级参考文献19

  • 1王玉伟,杨丽芹,孙静,邵长春.西酞普兰与氟西汀治疗抑郁症对照研究[J].临床精神医学杂志,2004,14(4):225-226. 被引量:69
  • 2梁琨,范雪云.西酞普兰与米安色林治疗老年抑郁症对照研究[J].临床精神医学杂志,2006,16(1):32-33. 被引量:9
  • 3Wu E, Greenberg PE, Yang E, et al. Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population. Curr Med Res Opin,2008,24 ( 9 ) : 2587 - 2595.
  • 4Moore N, Verdoux H, Fantino B. Prospective, muldcentre, randomized, double - bund study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmcol,2005,20 ( 3 ) : 131 - 137.
  • 5AlexHemeryck.SSRIS and Cytochrome p-450 Mediated Drug Drug interactions:An Update[J].Current Drug Metabolism,2002,3(13):37.
  • 6江开达主编.精神药理学.第4版.北京:人民卫生出版社,2007.420-421.
  • 7Kennedy SH, Anderson HF, Lam RW. Efficacy of escitalopram in the rteatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR : a meta-analysis. Psychiatry Neurosci ,2006,31 : 122-131.
  • 8Sanchez C, Bergqvist PB, Brennum LT, et al. Escitalopram, the Senantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berl) ,2003,167:353 -362.
  • 9Auquier P, Robitail S, Llorea PM, et al. Comparison of escitalopram and citalopram efficacy :a meta-analysis. Int J Psychiatry Clin Pract,2003,7: 259-268.
  • 10Kasper S, Spadeone C, Verpillat P, et al. Onset of action of escitalopram compared with other antidepressants:resuhs of a pooled analysis. Int Clin Psychopharmacology ,2006,21 : 105-110.

共引文献47

同被引文献218

引证文献19

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部